Xilio Development Financials

XLO Stock  USD 0.79  0.01  1.25%   
Based on the key indicators related to Xilio Development's liquidity, profitability, solvency, and operating efficiency, Xilio Development is not in a good financial situation at this time. It has a very high odds of going through financial crisis in November. At this time, Xilio Development's Net Tangible Assets are very stable compared to the past year. As of the 18th of October 2024, Property Plant And Equipment Net is likely to grow to about 13.5 M, while Net Debt is likely to drop (34.9 M). Key indicators impacting Xilio Development's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio2.873.016
Notably Down
Slightly volatile
Investors should never underestimate Xilio Development's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Xilio Development's cash flow, debt, and profitability to make informed and accurate decisions about investing in Xilio Development.

Net Income

(80.22 Million)

  
Understanding current and past Xilio Development Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Xilio Development's financial statements are interrelated, with each one affecting the others. For example, an increase in Xilio Development's assets may result in an increase in income on the income statement.

Xilio Development Stock Summary

Xilio Development competes with Champions Oncology, and Assembly Biosciences. Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Xilio Therapeutics, Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts. Xilio Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS98422T1007
CUSIP98422T100
LocationMassachusetts; U.S.A
Business Address828 Winter Street,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitexiliotx.com
Phone857 524 2466
CurrencyUSD - US Dollar

Xilio Development Key Financial Ratios

Xilio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Xilio Development's current stock value. Our valuation model uses many indicators to compare Xilio Development value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Xilio Development competition to find correlations between indicators driving Xilio Development's intrinsic value. More Info.
Xilio Development is rated second in return on equity category among its peers. It is rated third in return on asset category among its peers . At this time, Xilio Development's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Xilio Development's earnings, one of the primary drivers of an investment's value.

Xilio Development Systematic Risk

Xilio Development's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Xilio Development volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Xilio Development correlated with the market. If Beta is less than 0 Xilio Development generally moves in the opposite direction as compared to the market. If Xilio Development Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Xilio Development is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Xilio Development is generally in the same direction as the market. If Beta > 1 Xilio Development moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Xilio Development Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Xilio Development's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Xilio Development growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0162

At this time, Xilio Development's Price Earnings To Growth Ratio is very stable compared to the past year.

Xilio Development October 18, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Xilio Development help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Xilio Development. We use our internally-developed statistical techniques to arrive at the intrinsic value of Xilio Development based on widely used predictive technical indicators. In general, we focus on analyzing Xilio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Xilio Development's daily price indicators and compare them against related drivers.
When determining whether Xilio Development offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Xilio Development's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xilio Development Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xilio Development Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xilio Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xilio Development. If investors know Xilio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xilio Development listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.98)
Revenue Per Share
0.054
Return On Assets
(0.46)
Return On Equity
(1.30)
The market value of Xilio Development is measured differently than its book value, which is the value of Xilio that is recorded on the company's balance sheet. Investors also form their own opinion of Xilio Development's value that differs from its market value or its book value, called intrinsic value, which is Xilio Development's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xilio Development's market value can be influenced by many factors that don't directly affect Xilio Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xilio Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xilio Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xilio Development's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.